27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
As discussed in a prior blog post, in Gindel v. Centex Homes, 2018 Fla.App. LEXIS 13019, Florida’s ...
Read More >
With the passage of the Cannabis Regulation and Tax Act in June, Illinois became the 11th state in t...
Read More >
In a case of first impression, the Ninth Circuit overturned 35 years of precedent and ruled that ERI...
Read More >
On September 5, 2019, the Washington Supreme Court held that non-agricultural employees do not have ...
Read More >
James Doty, former Commissioner of the Public Company Accounting Oversight Board (PCAOB) was once as...
Read More >
The 2019 TRC Transportation Conference and Equipment Expo was held this week in Hot Springs, Arkansa...
Read More >